×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ITCI – intra-cellular therapies inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ITCI
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/2
10:34 am
itci
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its "neutral" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $132.00 price target on the stock.
Neutral
Report
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its "neutral" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $132.00 price target on the stock.
4/1
04:29 pm
itci
Johnson & Johnson Announces Expected Closing Date for Intra-Cellular Acquisition [Yahoo! Finance]
Low
Report
Johnson & Johnson Announces Expected Closing Date for Intra-Cellular Acquisition [Yahoo! Finance]
3/28
02:05 am
itci
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Low
Report
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
3/26
04:38 pm
itci
Jefferies profit misses estimates as bond trading, equity underwriting weaken [Yahoo! Finance]
Low
Report
Jefferies profit misses estimates as bond trading, equity underwriting weaken [Yahoo! Finance]
3/26
04:31 pm
itci
Jefferies profit falls on weaker bond trading, equity underwriting [Yahoo! Finance Canada]
Low
Report
Jefferies profit falls on weaker bond trading, equity underwriting [Yahoo! Finance Canada]
3/25
08:50 am
itci
5 Large Drug Stocks to Watch as Industry Recovers [Yahoo! Finance]
Neutral
Report
5 Large Drug Stocks to Watch as Industry Recovers [Yahoo! Finance]
3/20
02:06 am
itci
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Low
Report
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
3/12
02:11 am
itci
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Low
Report
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
10/30/2024
07:30 am
ITCI
intra-cellular therapies inc.
MISS
Report
9.6%
intra-cellular therapies inc.
8/7/2024
07:30 am
ITCI
intra-cellular therapies inc.
BEAT
Report
-5.8%
intra-cellular therapies inc.
5/7/2024
07:30 am
ITCI
intra-cellular therapies inc.
BEAT
Report
-2.9%
intra-cellular therapies inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/2
08:35 pm
itci
Form 4 Intra-Cellular Therapies For: Apr 02 Filed by: Salas Eduardo Rene
Neutral
Report
Form 4 Intra-Cellular Therapies For: Apr 02 Filed by: Salas Eduardo Rene
4/2
05:47 pm
itci
Form 4 Intra-Cellular Therapies For: Apr 02 Filed by: RIGGS RORY B
Neutral
Report
Form 4 Intra-Cellular Therapies For: Apr 02 Filed by: RIGGS RORY B
4/2
05:46 pm
itci
Form 4 Intra-Cellular Therapies For: Apr 02 Filed by: Halstead Michael
Neutral
Report
Form 4 Intra-Cellular Therapies For: Apr 02 Filed by: Halstead Michael
4/2
05:44 pm
itci
Form 4 Intra-Cellular Therapies For: Apr 02 Filed by: VAN NOSTRAND ROBERT L
Neutral
Report
Form 4 Intra-Cellular Therapies For: Apr 02 Filed by: VAN NOSTRAND ROBERT L
4/2
05:41 pm
itci
Form 4 Intra-Cellular Therapies For: Apr 02 Filed by: Neumann Mark
Neutral
Report
Form 4 Intra-Cellular Therapies For: Apr 02 Filed by: Neumann Mark
4/2
05:32 pm
itci
Form 4 Intra-Cellular Therapies For: Apr 02 Filed by: MARCUS JOEL S
Neutral
Report
Form 4 Intra-Cellular Therapies For: Apr 02 Filed by: MARCUS JOEL S
4/2
05:31 pm
itci
Form 4 Intra-Cellular Therapies For: Apr 02 Filed by: Mates Sharon
Neutral
Report
Form 4 Intra-Cellular Therapies For: Apr 02 Filed by: Mates Sharon
4/2
05:30 pm
itci
Form 4 Intra-Cellular Therapies For: Apr 02 Filed by: Narula Sanjeev
Neutral
Report
Form 4 Intra-Cellular Therapies For: Apr 02 Filed by: Narula Sanjeev
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
12/23
FDA Approves Intra-Cellular Therapies’ Novel Antipsychotic, CAPLYTA® (lumateperone) for the Treatment of Schizophrenia in Adults
194.7%
6/13 Intra-Cellular Therapies Announces FDA Advisory Committee Meeting to Review the NDA for Lumateperone for the Treatment of Schizophrenia in Adults 14.3%
6/14 Form DEFA14A Intra-Cellular Therapies 13.1%
7/8 Intra-Cellular drug fails bipolar depression study; shares fall 14% [Reuters (UK)] 12.8%
4/7 Intra-Cellular Therapies: This Small Cap Biotech Will Not Be Small For Long [Seeking Alpha] 11.4%
8/5 Intra-Cellular Therapies to Host Conference Call to Provide Regulatory Update Following Recent Meeting with FDA 8.5%
4/29 Intra-Cellular Therapies to Host First Quarter 2020 Financial Results Conference Call and Webcast 7.4%
9/7 Intra-Cellular Therapies Inc (NASDAQ: ITCI) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. 7.4%
1/6 Form S-3ASR Intra-Cellular Therapies 6.9%
10/15 Intra-Cellular Therapies Inc (NASDAQ: ITCI) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating. 5.8%
6/13 Intra-Cellular Therapies Announces FDA Advisory Committee Meeting to Review the NDA for Lumateperone for the Treatment of Schizophrenia in Adults 14.3%
6/14 Form DEFA14A Intra-Cellular Therapies 13.1%
7/8 Intra-Cellular drug fails bipolar depression study; shares fall 14% [Reuters (UK)] 12.8%
4/7 Intra-Cellular Therapies: This Small Cap Biotech Will Not Be Small For Long [Seeking Alpha] 11.4%
8/5 Intra-Cellular Therapies to Host Conference Call to Provide Regulatory Update Following Recent Meeting with FDA 8.5%
4/29 Intra-Cellular Therapies to Host First Quarter 2020 Financial Results Conference Call and Webcast 7.4%
9/7 Intra-Cellular Therapies Inc (NASDAQ: ITCI) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. 7.4%
1/6 Form S-3ASR Intra-Cellular Therapies 6.9%
10/15 Intra-Cellular Therapies Inc (NASDAQ: ITCI) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating. 5.8%
TOP News Decliners
7/8
Intra-Cellular Therapies Announces Positive Top-line Results from a Phase 3 Trial of Lumateperone in Patients with Bipolar Depression
-16.4%
12/23 Intra-Cellular drug approval augurs well for CNS stocks, Stifel says [Seeking Alpha] -14.1%
3/6 Intra-Cellular Therapies Inc (NASDAQ: ITCI) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. -13.4%
1/7 Intra-Cellular Therapies Prices Public Offering of Common Stock -12.7%
3/18 Intra-Cellular Therapies Inc (NASDAQ: ITCI) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. -8.7%
6/19 Form 4/A Intra-Cellular Therapies For: Nov 22 Filed by: Alafi Christopher D -8.4%
7/24 Form 8-K Intra-Cellular Therapies For: Jul 23 -8.2%
9/12 Form 424B3 Intra-Cellular Therapies -7.6%
2/21 Intra-Cellular Therapies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) -6.9%
1/8 Form 4 Intra-Cellular Therapies For: Jan 06 Filed by: Hineline Lawrence J. -5.1%
12/23 Intra-Cellular drug approval augurs well for CNS stocks, Stifel says [Seeking Alpha] -14.1%
3/6 Intra-Cellular Therapies Inc (NASDAQ: ITCI) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. -13.4%
1/7 Intra-Cellular Therapies Prices Public Offering of Common Stock -12.7%
3/18 Intra-Cellular Therapies Inc (NASDAQ: ITCI) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. -8.7%
6/19 Form 4/A Intra-Cellular Therapies For: Nov 22 Filed by: Alafi Christopher D -8.4%
7/24 Form 8-K Intra-Cellular Therapies For: Jul 23 -8.2%
9/12 Form 424B3 Intra-Cellular Therapies -7.6%
2/21 Intra-Cellular Therapies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) -6.9%
1/8 Form 4 Intra-Cellular Therapies For: Jan 06 Filed by: Hineline Lawrence J. -5.1%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: